These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3559975)
21. Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptors. Hoffmann IS; Talmaciu RK; Aquino R; Cubeddu LX J Pharmacol Exp Ther; 1996 Aug; 278(2):662-8. PubMed ID: 8768717 [TBL] [Abstract][Full Text] [Related]
22. Is the muscarinic receptor that mediates potentiation of dopamine release negatively coupled to the cyclic GMP system? Marchi M; Paudice P; Gemignani A; Raiteri M J Neurosci Res; 1987; 17(2):142-5. PubMed ID: 2438426 [TBL] [Abstract][Full Text] [Related]
23. Frequency-dependent release of acetylcholine and dopamine from rabbit striatum: its modulation by dopaminergic receptors. Cubeddu LX; Hoffmann IS J Neurochem; 1983 Jul; 41(1):94-101. PubMed ID: 6864232 [TBL] [Abstract][Full Text] [Related]
24. Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence. Joseph JA; Dalton TK; Hunt WA Brain Res; 1988 Jun; 454(1-2):140-8. PubMed ID: 2900662 [TBL] [Abstract][Full Text] [Related]
25. In vitro effects of organophosphorus anticholinesterases on muscarinic receptor-mediated inhibition of acetylcholine release in rat striatum. Liu J; Chakraborti T; Pope C Toxicol Appl Pharmacol; 2002 Jan; 178(2):102-8. PubMed ID: 11814330 [TBL] [Abstract][Full Text] [Related]
26. Transmitter release by non-receptor activation of the alpha-subunit of guanine nucleotide regulatory protein in rat striatal slices. Zelles T; Chernaeva L; Baranyi M; Déri Z; Adam-Vizi V; Vizi ES J Neurosci Res; 1995 Oct; 42(2):242-51. PubMed ID: 8568925 [TBL] [Abstract][Full Text] [Related]
27. Muscarinic potentiation of excitatory amino acid-evoked dopamine release in mesencephalic cells: specificity for the NMDA response and role of intracellular messengers. Allaoua H; Chaudieu I; Alonso R; Quirion R; Boksa P Synapse; 1993 Sep; 15(1):39-47. PubMed ID: 8310424 [TBL] [Abstract][Full Text] [Related]
28. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes. DeBoer P; Abercrombie ED J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558 [TBL] [Abstract][Full Text] [Related]
29. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity. Petkova-Kirova P; Giovannini MG; Kalfin R; Rakovska A Brain Res Bull; 2012 Dec; 89(5-6):177-84. PubMed ID: 22981453 [TBL] [Abstract][Full Text] [Related]
30. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices. Misu Y; Goshima Y; Ueda H; Kubo T J Pharmacol Exp Ther; 1985 Dec; 235(3):771-7. PubMed ID: 3001276 [TBL] [Abstract][Full Text] [Related]
31. Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: a deficit at the ligand-muscarinic receptor interface? Joseph JA; Dalton TK; Roth GS; Hunt WA Brain Res; 1988 Jun; 454(1-2):149-55. PubMed ID: 3136856 [TBL] [Abstract][Full Text] [Related]
32. Dopamine transporter mediated release of dopamine: role of chloride. Sitges M; Reyes A; Chiu LM J Neurosci Res; 1994 Sep; 39(1):11-22. PubMed ID: 7807588 [TBL] [Abstract][Full Text] [Related]
33. Depolarisation-evoked release of dopamine and histamine from brain tissue and studies on presynaptic dopamine-histamine interaction. Nowak JZ Pol J Pharmacol Pharm; 1985; 37(3):359-81. PubMed ID: 2866503 [TBL] [Abstract][Full Text] [Related]
35. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors. Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202 [TBL] [Abstract][Full Text] [Related]
36. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release. Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550 [TBL] [Abstract][Full Text] [Related]
37. Differential effects of the stereoisomers of 3PPP on dopaminergic and cholinergic neurotransmission in superfused slices of the corpus striatum. Arbilla S; Langer SZ Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):6-13. PubMed ID: 6092969 [TBL] [Abstract][Full Text] [Related]
38. Differential effects of phorbol ester on prefrontal cortex and striatal dopamine terminals: dependence on rate and duration of stimulation. Talmaciu RK; Hoffmann IS; Cubeddu LX J Pharmacol Exp Ther; 1989 Dec; 251(3):1160-5. PubMed ID: 2557413 [TBL] [Abstract][Full Text] [Related]
39. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors. Dwoskin LP; Zahniser NR J Pharmacol Exp Ther; 1986 Nov; 239(2):442-53. PubMed ID: 3772803 [TBL] [Abstract][Full Text] [Related]